Citigroup Inc Celldex Therapeutics, Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 25,265 shares of CLDX stock, worth $838,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,265

Previous 180,980 86.04%

Holding current value

$838,798

Previous $7.6 Million 87.69%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$32.76 - $42.56 $5.1 Million - $6.63 Million	-155,715 Reduced 86.04%	25,265 $935,000
Q1 2024 May 10, 2024	BUY	$35.22 - $51.88 $4.18 Million - $6.15 Million	118,639 Added 190.31%	180,980 $7.6 Million
Q4 2023 Feb 09, 2024	SELL	$22.61 - $40.65 $158,586 - $285,119	-7,014 Reduced 10.11%	62,341 $2.47 Million
Q3 2023 Nov 09, 2023	SELL	$25.45 - $37.46 $37,640 - $55,403	-1,479 Reduced 2.09%	69,355 $1.91 Million
Q2 2023 Aug 10, 2023	SELL	$30.29 - $38.28 $1.43 Million - $1.8 Million	-47,071 Reduced 39.92%	70,834 $2.4 Million
Q1 2023 May 11, 2023	BUY	$34.78 - $47.43 $1.89 Million - $2.58 Million	54,408 Added 85.69%	117,905 $4.24 Million
Q4 2022 Feb 09, 2023	SELL	$27.78 - $45.38 $3.5 Million - $5.71 Million	-125,915 Reduced 66.48%	63,497 $2.83 Million
Q3 2022 Nov 10, 2022	BUY	$22.7 - $37.57 $765,784 - $1.27 Million	33,735 Added 21.67%	189,412 $5.32 Million
Q2 2022 Aug 10, 2022	BUY	$20.5 - $37.33 $1.89 Million - $3.44 Million	92,158 Added 145.09%	155,677 $4.2 Million
Q1 2022 May 12, 2022	SELL	$27.64 - $39.32 $1.53 Million - $2.18 Million	-55,529 Reduced 46.64%	63,519 $2.16 Million
Q4 2021 Feb 10, 2022	BUY	$35.68 - $56.27 $347,487 - $548,013	9,739 Added 8.91%	119,048 $4.6 Million
Q3 2021 Nov 10, 2021	BUY	$28.95 - $55.99 $3.16 Million - $6.12 Million	109,309 New	109,309 $5.9 Million

Others Institutions Holding CLDX

# of Institutions

195

Shares Held

63.4M

Call Options Held

206K

Put Options Held

176K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.55B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account